BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 19122019)

  • 1. Risperidone-associated increase in triglyceride levels.
    Weinbrenner A; Peus V; Inta D; Englisch S; Zink M
    Am J Psychiatry; 2009 Jan; 166(1):113-4. PubMed ID: 19122019
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dyslipidemia and schizophrenia].
    Wetterling T; Schneider B; Weber B
    Psychiatr Prax; 2007 Jul; 34(5):223-9. PubMed ID: 17160750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapidly worsening hypertriglyceridemia during treatment with risperidone.
    Kohen I; Manu P
    Am J Ther; 2010; 17(2):216-8. PubMed ID: 19455018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Utilisation of atypical antipsychotic drugs in institutionalised elderly persons and prevalence of metabolic alterations].
    Martínez Romero G; Peris Martí JF; Gomar Fayos J; Navarro Gosalbez M; Quintana Vargas I; Muelas Tirado J
    Farm Hosp; 2010; 34(3):139-47. PubMed ID: 20434929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of treatment refractory schizophrenia.
    Morrison DP
    Br J Psychiatry Suppl; 1996 Dec; (31):15-20. PubMed ID: 8968651
    [No Abstract]   [Full Text] [Related]  

  • 6. Olanzapine versus risperidone: weight gain and elevation of serum triglyceride levels.
    Garyfallos G; Dimelis D; Kouniakis P; Sidiropoulos N; Karastergiou A; Lavrentiadis G; Giouzepas J; Fokas K
    Eur Psychiatry; 2003 Oct; 18(6):320-1. PubMed ID: 14611929
    [No Abstract]   [Full Text] [Related]  

  • 7. Significant elevations of prolactin levels in patients who shifted from conventional depot antipsychotics to long-acting risperidone.
    Lai YC; Chiou CC; Chen CH; Huang MC
    J Clin Psychopharmacol; 2007 Oct; 27(5):523-4. PubMed ID: 17873693
    [No Abstract]   [Full Text] [Related]  

  • 8. [Urinary retention with risperidone].
    Siepmann M; Olbrich H
    Psychiatr Prax; 1997 Jul; 24(4):209. PubMed ID: 9340666
    [No Abstract]   [Full Text] [Related]  

  • 9. Olanzapine-induced elevation of plasma triglyceride levels.
    Sheitman BB; Bird PM; Binz W; Akinli L; Sanchez C
    Am J Psychiatry; 1999 Sep; 156(9):1471-2. PubMed ID: 10484969
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of atypical antipsychotics on weight and serum lipid levels.
    Meyer JM
    J Clin Psychiatry; 2001; 62 Suppl 27():27-34; discussion 40-1. PubMed ID: 11806486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of risperidone on lipid profile.
    Khalili H; Dashti-Khavidaki S; Okhovatpour H; Ghaeli P
    Ann Pharmacother; 2007 May; 41(5):899-900. PubMed ID: 17426072
    [No Abstract]   [Full Text] [Related]  

  • 12. Risperidone-induced priapism.
    Makesar D; Thome J
    World J Biol Psychiatry; 2007; 8(1):45-7. PubMed ID: 17366350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interaction between superoxide dismutase and prolactin is involved in response to haloperidol and risperidone treatment in schizophrenia: a double-blind and randomized study.
    Zhang XY; Zhou DF; Cao LY; Wu GY; Shen YC
    J Clin Psychopharmacol; 2006 Feb; 26(1):103-5. PubMed ID: 16415724
    [No Abstract]   [Full Text] [Related]  

  • 15. Prolactin elevation of the antipsychotic risperidone is predominantly related to its 9-hydroxy metabolite.
    Melkersson KI
    Hum Psychopharmacol; 2006 Dec; 21(8):529-32. PubMed ID: 17094165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized clinical comparison of perospirone and risperidone in patients with schizophrenia: Kansai Psychiatric Multicenter Study.
    Okugawa G; Kato M; Wakeno M; Koh J; Morikawa M; Matsumoto N; Shinosaki K; Yoneda H; Kishimoto T; Kinoshita T
    Psychiatry Clin Neurosci; 2009 Jun; 63(3):322-8. PubMed ID: 19566763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risperidone induced galactorrhea: a case analysis.
    Hariharan J; Mohsin J
    WMJ; 2002; 101(8):41-3. PubMed ID: 12557612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased plasma brain-derived neurotropic factor, not nerve growth factor-Beta, in schizophrenia patients with better response to risperidone treatment.
    Lee BH; Kim YK
    Neuropsychobiology; 2009; 59(1):51-8. PubMed ID: 19270464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increases in triglyceride levels are associated with clinical response to clozapine treatment.
    Lally J; Gallagher A; Bainbridge E; Avalos G; Ahmed M; McDonald C
    J Psychopharmacol; 2013 Apr; 27(4):401-3. PubMed ID: 23325369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of risperidone on ghrelin and glucose in schizophrenia.
    Cohen D
    Psychiatry Clin Neurosci; 2007 Oct; 61(5):576. PubMed ID: 17875041
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.